搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
Medindia
3 天
Constipation: A Warning Sign of Cancer That You Shouldn't Ignore
Can chronic constipation indicate cancer? Learn how to recognize warning signs, take early action, and protect your health.
6 天
We Spoke To A Colorectal Cancer Doctor Who Shared 5 Things We Should All Stop Doing Immediately
Cases of colorectal cancer have been rapidly increasing among young adults, so we spoke to a doctor to get some helpful tips.
7 天
Can constipation cause cancer? Experts explain
Chronic constipation, often dismissed as a minor issue, can sometimes signal serious underlying conditions like colon, rectal ...
7 天
Mainz Biomed partners with Quest for colorectal cancer screening test
Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...
7 天
More Pleasant Colon Cancer Screening? A New Blood Test Makes It Possible
Colon cancer screening is only effective if you complete the test. With 53,000 Americans expected to die from colon cancer in ...
7 天
Putting Yourself First: Early Detection for Colon Cancer Matters
A non-invasive, easy-to-use test, like the Cologuard test, is a simple and effective way to screen for colorectal cancer. In ...
8 天
I’m a surgeon — eat these 4 foods if you’re having trouble pooping, the first may ...
Rangarajan pointed out that studies have linked a high frequency of nut consumption — typically around 20 to 30 grams a day — ...
8 天
Mainz Biomed, Quest Diagnostics To Commercialize NextGen Colorectal Cancer Screening Test ...
(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...
8 天
Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory ...
Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA ApprovalBERKELEY ...
10 天
Causes, symptoms and treatment of bowel cancer: A rising health risk among youngsters
In several countries, cases of bowel cancer are rising among younger people in the 25-49 age group as compared to older ...
Seeking Alpha
14 天
Exact Sciences: Profitability Remains Elusive
The company’s main revenue source is Cologuard, a non-invasive pre- and colorectal cancer [CRC] screening test that was first ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈